Posted November 28, 2007
Trimeris Faces Lawsuit over HIV Drug
Post a comment
Print this storyE-mail story
Share
Morrisville, N.C. —
Biopharmaceutical development firm Trimeris faces a lawsuit over the HIV drug it developed called Fuzeon.
In a Securities and Exchange Commission filing on Tuesday, Trimeris (Nasdaq: TRMS) said it had been sued by Novartis. Roche, Trimeris’ partner in developing and selling Fuzeon, is also included in the suit.
Novartis is alleging patent infringement. According to Trimeris, Novartis received the patent at the center of the case, about one month ago.
Fuzeon was approved for sale in 2003.
Featured
Hot Off The Wire
- Red Hat's new Fedora lead; Cree LED breakthrough; Google, Cisco top 'green' list; Oracle rejects SAP settlement; Yahoo board shakeup
- Will Cisco report progress in its turnaround efforts?
- Cisco server fire threat; Lenovo Android upgrade; cloud startup vs. Cisco; Epic's Blesinski to host awards; Google 'Solve for X'
E-mail Preferences
